share_log

Ladenburg Thalmann Maintains Buy on Alterity Therapeutics, Lowers Price Target to $10

Benzinga ·  Jun 5, 2023 06:55

Ladenburg Thalmann analyst Aydin Huseynov maintains Alterity Therapeutics (NASDAQ:ATHE) with a Buy and lowers the price target from $20 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment